Design and Synthesis of Novel Heterocyclic Carboxamide Analogues As Potential Urease Enzyme Inhibitors
International Journal of Drug Delivery Technology · 02.06.2026 · 16 (43s)
DOI: 10.25258/ijddt.16.43s.77 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Tarigoppula Sunitha und 7 weiteren Autor:innen.
Abstract (Originalsprache)
The pathogenic involvement of urease in severe gastrointestinal disorders, particularly Helicobacter pylori infections, as well as its contribution to agricultural inefficiencies, highlights the urgent need for the development of novel, safe, and potent inhibitors. In the present study, a new series of thiazole-2-carboxamide analogues (1a–1c) was rationally designed, synthesized, and structurally characterized using FT-IR, NMR (1H) techniques. The in vitro urease inhibitory activity of the synthesized compounds was assessed against Jack bean urease employing the indophenol colorimetric assay. Among the evaluated analogues, the 4-methoxy-substituted compound 1b exhibited remarkable inhibitory potency, with an IC₅₀ value of 12.45 ± 0.12 μM, significantly surpassing the standard inhibitor thiourea (IC₅₀ = 21.25 ± 0.15 μM). Structure–activity relationship (SAR) analysis indicated that electron-donating substituents enhance inhibitory activity, likely by increasing the electron density and basicity of the carboxamide moiety. Enzyme kinetic studies based on Lineweaver–Burk plots revealed that compound 1b acts as a competitive inhibitor, with a calculated inhibition constant (Kᵢ) of 8.12 μM. Furthermore, molecular docking studies within the urease active site (PDB ID: 3LA4) demonstrated stable bidentate coordination between the ligand and the bimetallic nickel center (Ni301 and Ni302), supporting its strong binding affinity. In addition, SwissADME analysis predicted favorable pharmacokinetic properties, including high gastrointestinal absorption, blood–brain barrier permeability, and full compliance with Lipinski's Rule of Five. Collectively, these findings identify compound 1b as a promising, drug-like lead candidate for the development of urease-targeted therapeutic agents.
Zitieren
APA
Sunitha, T., Dixena, D., Das, A., Boruah, P., Dema, T., K, Y., Lal, S., & Meera, R. (2026). Design and Synthesis of Novel Heterocyclic Carboxamide Analogues As Potential Urease Enzyme Inhibitors. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.77
Vancouver
Sunitha T, Dixena D, Das A, Boruah P, Dema T, K Y, et al. Design and Synthesis of Novel Heterocyclic Carboxamide Analogues As Potential Urease Enzyme Inhibitors. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.77
BibTeX
@article{Sunitha2026,
author = {Sunitha, Tarigoppula and Dixena, Durgesh and Das, Aaditya and Boruah, Pompi and Dema, Tsering and K, Yuvarani and Lal, Sohan and Meera, R.},
title = {Design and Synthesis of Novel Heterocyclic Carboxamide Analogues As Potential Urease Enzyme Inhibitors},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {43s},
doi = {10.25258/ijddt.16.43s.77}
}
EUVIMED